i have skimmed through the filing and overall i think i came up with these points:
All big holders wanted Dan out because he wanted to go it all alone, and to do that he would have had to dilute more, if he was still here we would have had another round of dilution in the next 6 months.
Also he was a liability to the company, couple of cases filed against ADXS in 2015 due to his self enriching practices.
The big players wanted Dan out and wanted quick money with licensing deals.
IT IS OBVIOUS from current filing that this is what current management is focusing on, they mentioned more than once focus on building / creating "shareholder value"
Focusing on these 4 franchises is probably for 2 main reasons one is that with ADXS NEO and HOT i believe AXAL will be obsolete as the former are more advanced technically speaking however as AXAL is far in clinical trials that is why they are continuing to push for its marketing, they probably plan to make some money out of it in next few years until ADXS NEO enters market, ADXS NEO will need probably 6 years to get to the stage, Current stage will finish in about 3 years in 2020 and if results are brilliant and with AMGN pushing for it maybe we can jump directly from phase one to a registration trial.
I don't think they are heading to a full buyout but more to individual franchise buyouts where each company will take a piece of the pie AMGN getting the biggest piece with ADXS NEO
my only question is why did they drop HER2, 2 explanations one is it didn't work which i don't believe thats the case, the second which goes along with all what i wrote above is that they are trying to consolidate spending and since ADXS NEO is going to make all constructs obsolete it is not worth starting trials at this point using this technology as it will also need more funding with more dilution.
I think taking a step back and looking at things, Dilution Dan didn't earn that name for nothing, and he is now out and focus is on creating share holder value and advancing less constructs more efficiently.
Although i've always been positive about this stock, i think we are now at a buying opportunity, i do expect some licensing deals are in the works, Big money wants to monetize ... they waited too long, any signs of positive data with combos or other trials will lead to licensing deals.
If you have read so far ... wow :) let me know your thoughts about the above !
